MétaCan
Menu
← Back to cohort
Record W2395063215

Reduction of myocardial ischemia with simvastatin in addition to conventional treatment in patients with chronic coronary artery disease.

2004· article· en· W2395063215 on OpenAlexaboutno aff
Verri, Cunha Ab, Tessarolo Le, Carneiro Rc, Romêo Filho Lj

Bibliographic record

VenuePubMed · 2004
Typearticle
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsnot available
Fundersnot available
KeywordsSimvastatinMedicineCoronary artery diseaseInternal medicineCardiologyDyslipidemiaCholesterolPlaceboIschemiaDiseaseCoronary atherosclerosisAnginaRisk factorArteryRandomized controlled trialMyocardial infarctionPathology
DOInot available

Abstract

fetched live from OpenAlex

BACKGROUND: Coronary artery disease is becoming more prevalent every day. We now know that controlling the risk factors for this pathology is of the utmost importance, not only to prevent the formation of atheromatous plaques (primary prevention), but also to slow its progression, or even promote regression of existing plaques (secondary prevention). There is no longer any doubt that an increase in serum cholesterol is essential for the development and progression of atherosclerosis. Therefore, lowering cholesterol levels is a key factor in controlling this disease. It has been shown that cholesterol reduction with statins is associated with a reduction in cardiovascular morbidity and mortality. It has also been demonstrated that reducing cholesterol restores peripheral and coronary vasodilation even in subjects with no angiographic evidence of the disease. OBJECTIVE: The present study aimed at assessing the effect of simvastatin in reducing myocardial ischemia in patients with chronic atherosclerotic coronary artery disease. PATIENTS AND METHODS: Twenty-five patients with stable angina and dyslipidemia undergoing clinical treatment were studied prospectively. Their lipid profile was analyzed and the diagnosis of effort-induced ischemia was confirmed by means of exercise testing. They were then randomly distributed in two groups: the simvastatin group and the placebo group. After a four- to six-month follow-up period (average of 5.72 months), they underwent new laboratory and exercise tests. RESULTS: A significant reduction in the variation of total cholesterol (p < 0.0002) and LDL-C levels (p < 0.001) was observed in the simvastatin group, compared to the placebo group. The parameters assessed during the exercise test revealed a significant improvement in ST-segment depression during effort (p < 0.046), as well as a decrease in precordial pain in the treated group during exertion, when comparing pre- and post-treatment periods. Patients receiving simvastatin also improved their functional capacity (p < 0.016), subjectively assessed by the angina pectoris classification of the Canadian Cardiovascular Society. CONCLUSIONS: These results suggest that the association of simvastatin and conventional treatment in patients with stable angina reduces effort-induced ischemia, and can be used with this group of patients, particularly those considered ineligible for invasive therapeutic intervention.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.203
Teacher spread0.195 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2004
Admission routes1
Has abstractyes

Explore more

Same venuePubMed→Same topicLipoproteins and Cardiovascular Health→French-language works237,207→